Crossmark

Current Management of Residual Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea: Insights for Optimizing Patient Outcomes

Published Online: 2021-10-18

Published Print: 2021-12

Authors

Mehra, Reena

Heinzer, Raphael

Castillo, Pablo
Funding

Funding for this research was provided by:

Jazz Pharmaceuticals
License Information

Text and Data Mining valid from 2021-10-18

Version of Record valid from 2021-10-18
More Information

Article History

Received: 12 August 2021

Accepted: 1 October 2021

First Online: 18 October 2021

Document is current